Literature DB >> 29296518

The hepatic microenvironment essentially determines tumor cell dormancy and metastatic outgrowth of pancreatic ductal adenocarcinoma.

Lennart Lenk1, Maren Pein2,3, Olga Will4, Beatriz Gomez1, Fabrice Viol5, Charlotte Hauser6, Jan-Hendrik Egberts6, Jan-Paul Gundlach6, Ole Helm1, Sanjay Tiwari4, Ralf Weiskirchen7, Stefan Rose-John8, Christoph Röcken9, Wolfgang Mikulits10, Patrick Wenzel11, Günter Schneider11, Dieter Saur11, Heiner Schäfer1, Susanne Sebens1.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is often diagnosed when liver metastases already emerged. This study elucidated the impact of hepatic stromal cells on growth behavior of premalignant and malignant pancreatic ductal epithelial cells (PDECs). Liver sections of tumor-bearing KPC mice comprised micrometastases displaying low proliferation located in an unobtrusive hepatic microenvironment whereas macrometastases containing more proliferating cells were surrounded by hepatic myofibroblasts (HMFs). In an age-related syngeneic PDAC mouse model livers with signs of age-related inflammation exhibited significantly more proliferating disseminated tumor cells (DTCs) and micrometastases despite comparable primary tumor growth and DTC numbers. Hepatic stellate cells (HSC), representing a physiologic liver stroma, promoted an IL-8 mediated quiescence-associated phenotype (QAP) of PDECs in coculture. QAP included flattened cell morphology, Ki67-negativity and reduced proliferation, elevated senescence-associated β galactosidase activity and diminished p-Erk/p-p38-ratio. In contrast, proliferation of PDECs was enhanced by VEGF in the presence of HMF. Switching the micromilieu from HSC to HMF or blocking VEGF reversed QAP in PDECs. This study demonstrates how HSCs induce and maintain a reversible QAP in disseminated PDAC cells, while inflammatory HMFs foster QAP reversal and metastatic outgrowth. Overall, the importance of the hepatic microenvironment in induction and reversal of dormancy during PDAC metastasis is emphasized.

Entities:  

Keywords:  dormancy; inflammation; metastases; pancreatic cancer; tumor stroma

Year:  2017        PMID: 29296518      PMCID: PMC5739558          DOI: 10.1080/2162402X.2017.1368603

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  50 in total

1.  Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia.

Authors:  Mitsuro Kanda; Hanno Matthaei; Jian Wu; Seung-Mo Hong; Jun Yu; Michael Borges; Ralph H Hruban; Anirban Maitra; Kenneth Kinzler; Bert Vogelstein; Michael Goggins
Journal:  Gastroenterology       Date:  2012-01-05       Impact factor: 22.682

2.  Lymphoid neogenesis and immune infiltration in aged liver.

Authors:  Pallavi Singh; Zeynep Z Coskun; Catriona Goode; Adam Dean; LuAnn Thompson-Snipes; Gretchen Darlington
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

Review 3.  State of the art and future directions of pancreatic ductal adenocarcinoma therapy.

Authors:  Cindy Neuzillet; Annemilaï Tijeras-Raballand; Philippe Bourget; Jérôme Cros; Anne Couvelard; Alain Sauvanet; Marie-Pierre Vullierme; Christophe Tournigand; Pascal Hammel
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

Review 4.  Mechanisms of disseminated cancer cell dormancy: an awakening field.

Authors:  María Soledad Sosa; Paloma Bragado; Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2014-08-14       Impact factor: 60.716

5.  Inflammation Triggers Zeb1-Dependent Escape from Tumor Latency.

Authors:  Jasmine M De Cock; Tsukasa Shibue; Anushka Dongre; Zuzana Keckesova; Ferenc Reinhardt; Robert A Weinberg
Journal:  Cancer Res       Date:  2016-08-16       Impact factor: 12.701

6.  Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.

Authors:  S Sebens Müerköster; V Werbing; B Sipos; M A Debus; M Witt; M Grossmann; D Leisner; J Kötteritzsch; H Kappes; G Klöppel; P Altevogt; U R Fölsch; H Schäfer
Journal:  Oncogene       Date:  2006-11-06       Impact factor: 9.867

7.  Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.

Authors:  Barbara Grünwald; Veronika Harant; Susanne Schaten; Monika Frühschütz; Ria Spallek; Bastian Höchst; Katharina Stutzer; Sonja Berchtold; Mert Erkan; Olga Prokopchuk; Marc Martignoni; Irene Esposito; Mathias Heikenwalder; Aayush Gupta; Jens Siveke; Paul Saftig; Percy Knolle; Dirk Wohlleber; Achim Krüger
Journal:  Gastroenterology       Date:  2016-08-06       Impact factor: 22.682

8.  Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.

Authors:  Jan-Hendrik Egberts; Vera Cloosters; Andreas Noack; Bodo Schniewind; Lutz Thon; Stefanie Klose; Bastian Kettler; Corinna von Forstner; Christian Kneitz; Jürgen Tepel; Dieter Adam; Harald Wajant; Holger Kalthoff; Anna Trauzold
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

9.  Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer.

Authors:  Philippe Rougier; Hanno Riess; Robert Manges; Petr Karasek; Yves Humblet; Carlo Barone; Armando Santoro; Sylvie Assadourian; Laurence Hatteville; Philip A Philip
Journal:  Eur J Cancer       Date:  2013-04-30       Impact factor: 9.162

10.  CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.

Authors:  Colin W Steele; Saadia A Karim; Joshua D G Leach; Peter Bailey; Rosanna Upstill-Goddard; Loveena Rishi; Mona Foth; Sheila Bryson; Karen McDaid; Zena Wilson; Catherine Eberlein; Juliana B Candido; Mairi Clarke; Colin Nixon; John Connelly; Nigel Jamieson; C Ross Carter; Frances Balkwill; David K Chang; T R Jeffry Evans; Douglas Strathdee; Andrew V Biankin; Robert J B Nibbs; Simon T Barry; Owen J Sansom; Jennifer P Morton
Journal:  Cancer Cell       Date:  2016-06-02       Impact factor: 38.585

View more
  16 in total

Review 1.  The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities.

Authors:  Yohei Masugi
Journal:  Cancers (Basel)       Date:  2022-07-05       Impact factor: 6.575

Review 2.  Tumor microenvironment participates in metastasis of pancreatic cancer.

Authors:  Bo Ren; Ming Cui; Gang Yang; Huanyu Wang; Mengyu Feng; Lei You; Yupei Zhao
Journal:  Mol Cancer       Date:  2018-07-30       Impact factor: 27.401

Review 3.  Paracrine and cell autonomous signalling in pancreatic cancer progression and metastasis.

Authors:  Stacy K Thomas; Jesse Lee; Gregory L Beatty
Journal:  EBioMedicine       Date:  2020-03-02       Impact factor: 8.143

4.  What Is the Storage Effect, Why Should It Occur in Cancers, and How Can It Inform Cancer Therapy?

Authors:  Anna K Miller; Joel S Brown; David Basanta; Nancy Huntly
Journal:  Cancer Control       Date:  2020 Jul-Aug       Impact factor: 3.302

Review 5.  The liver metastatic niche: modelling the extracellular matrix in metastasis.

Authors:  James Drew; Laura M Machesky
Journal:  Dis Model Mech       Date:  2021-04-15       Impact factor: 5.758

6.  Relationship between a 7-mRNA signature of the pancreatic adenocarcinoma microenvironment and patient prognosis (a STROBE-compliant article).

Authors:  Qing-Lin He; Hai-Xing Jiang; Xiang-Lian Zhang; Shan-Yu Qin
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

7.  Pseudopterosin and O-Methyltylophorinidine Suppress Cell Growth in a 3D Spheroid Co-Culture Model of Pancreatic Ductal Adenocarcinoma.

Authors:  Bailu Xie; Jan Hänsel; Vanessa Mundorf; Janina Betz; Irene Reimche; Mert Erkan; Ibrahim Büdeyri; Anne Gesell; Russell G Kerr; Ni Putu Ariantari; Haiqian Yu; Peter Proksch; Nicole Teusch; Randall J Mrsny
Journal:  Bioengineering (Basel)       Date:  2020-06-14

8.  Liver metastasis of pancreatic cancer: the hepatic microenvironment impacts differentiation and self-renewal capacity of pancreatic ductal epithelial cells.

Authors:  Hendrike Knaack; Lennart Lenk; Lisa-Marie Philipp; Lauritz Miarka; Sascha Rahn; Fabrice Viol; Charlotte Hauser; Jan-Hendrik Egberts; Jan-Paul Gundlach; Olga Will; Sanjay Tiwari; Wolfgang Mikulits; Udo Schumacher; Jan G Hengstler; Susanne Sebens
Journal:  Oncotarget       Date:  2018-08-03

9.  Survival benefits of neoadjuvant chemo(radio)therapy versus surgery first in patients with resectable or borderline resectable pancreatic cancer: a systematic review and meta-analysis.

Authors:  Long Pan; Jing Fang; Chenhao Tong; Mingyu Chen; Bin Zhang; Sarun Juengpanich; Yifan Wang; Xiujun Cai
Journal:  World J Surg Oncol       Date:  2019-12-31       Impact factor: 2.754

Review 10.  Cancer Cell Dormancy in Metastasis.

Authors:  Matthew A Summers; Michelle M McDonald; Peter I Croucher
Journal:  Cold Spring Harb Perspect Med       Date:  2020-04-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.